Franda Q
Head of Investor Relations at LIVZON PHARMACEUTICAL GROUP INC. | Hong Kong SAR
Franda Q’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Head of Investor Relations at LIVZON PHARMACEUTICAL GROUP INC. in November 2025 - Present
Equity Research Senior Associate at Macquarie Group in April 2023 - March 2025
Equity Research Senior Analyst at BOCI in April 2021 - April 2023
Structured Finance at CTBC Bank in January 2020 - December 2021
The Hong Kong University of Science and Technology, Master of Science - MS (part-time), June 2026
The Chinese University of Hong Kong, Master's degree, June 2026
Zhejiang University, Bachelor’s Degree, June 2026
Livzon is Always Committed to Human Healthcare Livzon Pharmaceutical Group Inc., established in January 1985 with registered capital of 953 million yuan, is a comprehensive pharmaceutical group company integrating pharmaceutical R&D, production and sales, with more than 9,000 employees. In 1993, Livzon A and B shares have been listed. In 2014, the company completed the conversion from B shares to H shares, making it one of the few listed pharmaceutical companies with A+H shares in the capital market. In 2020, annual operating revenue of 10.5billion yuan, net profit of 2.131 billion yuan and R&D investment of 989 million yuan. Livzon is committed to ensuring effective, safe and stable products. The Group's pharmaceutical enterprises have established a sound quality management system. As of 2018, Total 31 production lines of 4 pharmaceutical subsidiaries have passed GMP certification. 28 varieties of 4 API companies have passed GMP certification and other 11 varieties have passed veterinary medicine GMP certification. 15 API varieties have passed the field inspection of international certification and obtained 20 international certification certificates.
Discover more about LIVZON PHARMACEUTICAL GROUP INC.
Pharmaceutical Ingredients International Marketing
API business development (BD) and the application of AI technology in the pharmaceutical field. Promoting the growth of API sales and the efficient application of AI technology in business opportunity acquisition and sales through market insights and technology integration, he...
丽珠医药集团 - 投资者关系总监
负责管理集团A股及港股投资者关系，同时协助公司副总、董秘进行市值管理、战略规划、信息披露、投融资等工作。
1. 及时了解公司的研发、生产、销售等经营重大信息，同时整理收集资本市场及生物医药行�...
Director of Quality, Biosciences & Regulatory Affairs at Livzon
Director of Quality, Biosciences & Regulatory Affairs at Livzon
(Nov 2016 – Present)
technologist
technologist for Semaglutide’s APIs
LIVZON API
首席科学家/CSO at Livzon API
(Jun 2017 – Present)
丽珠医药 - Data Management & Statistics Director
Data Management & Statistics Director at Livzon Pharmaceutical Group Inc.
(Jul 2019 – Present)
What is Franda Q email address?
Email Franda Q at [email protected]. This email is the most updated Franda Q's email found in 2026.
What is Franda Q phone number?
Franda Q phone number is +85267071697.
How to contact Franda Q?
To contact Franda Q send an email to [email protected]. If you want to call Franda Q try calling on +85267071697. (updated on December 09, 2025)
What company does Franda Q work for?
Franda Q works for LIVZON PHARMACEUTICAL GROUP INC..
What is Franda Q's role at LIVZON PHARMACEUTICAL GROUP INC.?
Franda Q is Head of Investor Relations
What industry does Franda Q work in?
Franda Q works in the Financial Services industry.
